Kate Rochlin - 22 Dec 2025 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Operating Officer
Signature
/s/ William Ho, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
22 Dec 2025
Net transactions value
+$10,001
Form type
4
Filing time
23 Dec 2025, 18:20:14 UTC
Previous filing
07 May 2025
Next filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rochlin Kate Chief Operating Officer C/O IN8BIO, INC., 350 5TH AVE. SUITE 5330, NEW YORK /s/ William Ho, Attorney-in-Fact 23 Dec 2025 0001898521

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award $10,001 +7,247 +394% $1.38 9,085 22 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effective June 3, 2025, the Issuer effected a 1-for-30 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.